In vitro and pharmacokinetic properties of the carbapenems.
作者信息
Wise R
出版信息
Antimicrob Agents Chemother. 1986 Sep;30(3):343-9. doi: 10.1128/AAC.30.3.343.
Abstract
摘要
相似文献
1
In vitro and pharmacokinetic properties of the carbapenems.
Antimicrob Agents Chemother. 1986 Sep;30(3):343-9. doi: 10.1128/AAC.30.3.343.
2
Studies on the OA-6129 group of antibiotics, new carbapenem compounds. II. In vitro evaluation.
J Antibiot (Tokyo). 1982 Oct;35(10):1264-70. doi: 10.7164/antibiotics.35.1264.
3
Structure-activity relationships in the 2-arylcarbapenem series: synthesis of 1-methyl-2-arylcarbapenems.
J Med Chem. 1987 May;30(5):871-80. doi: 10.1021/jm00388a022.
4
Synthesis and biological activity of 1beta-methyl-2-[5'-isoxazoloethenylpyrrolidin-3'-ylthio]carbapenems.
Bioorg Med Chem Lett. 2000 Dec 18;10(24):2799-802. doi: 10.1016/s0960-894x(00)00575-8.
5
Cephalosporin, thienamycin, and monobactam antibiotics: a review of antimicrobial activity, pharmacology, and safety.
J Foot Surg. 1987 Jan-Feb;26(1 Suppl):S42-50.
6
[Adequate use of parenteral antibacterial agents: panipenem/betamipron (discussion)].
Jpn J Antibiot. 2012 Apr;65(2):99-110.
7
Synthesis and in vitro activity of C-2 quaternary heterocyclic alkylthio carbapenems.
J Antibiot (Tokyo). 1987 Dec;40(12):1707-15. doi: 10.7164/antibiotics.40.1707.
8
A novel carbapenem antibiotic, SM-7338 structure-activity relationships.
J Antibiot (Tokyo). 1990 May;43(5):519-32. doi: 10.7164/antibiotics.43.519.
9
Imipenem/cilastatin: the first carbapenem antibiotic.
Drug Intell Clin Pharm. 1985 Dec;19(12):895-9.
10
Synthesis and in vitro activity of 1 beta-methyl C-2 quaternary heterocyclic alkylthio carbapenems.
J Med Chem. 1989 Mar;32(3):601-4. doi: 10.1021/jm00123a015.
引用本文的文献
1
Imipenem/cilastatin encapsulated polymeric nanoparticles for destroying carbapenem-resistant bacterial isolates.
J Nanobiotechnology. 2017 Apr 11;15(1):29. doi: 10.1186/s12951-017-0262-9.
2
Identification and characterization of the carbapenem MM 4550 and its gene cluster in Streptomyces argenteolus ATCC 11009.
Chembiochem. 2014 Jan 24;15(2):320-31. doi: 10.1002/cbic.201300319. Epub 2014 Jan 13.
3
Antimicrobial activity of the new carbapenem biapenem compared to imipenem, meropenem and other broad-spectrum beta-lactam drugs.
Eur J Clin Microbiol Infect Dis. 1993 May;12(5):384-91. doi: 10.1007/BF01964439.
4
Meropenem clinical pharmacokinetics.
Clin Pharmacokinet. 1995 Apr;28(4):275-86. doi: 10.2165/00003088-199528040-00002.
5
Sequential, single-dose pharmacokinetic evaluation of meropenem in hospitalized infants and children.
Antimicrob Agents Chemother. 1995 Aug;39(8):1721-5. doi: 10.1128/AAC.39.8.1721.
6
In vitro activity and beta-lactamase stability of a new carbapenem, SM-7338.
Antimicrob Agents Chemother. 1989 Jul;33(7):1009-18. doi: 10.1128/AAC.33.7.1009.
7
Multicenter in vitro evaluation of SM-7338, a new carbapenem.
Antimicrob Agents Chemother. 1989 Apr;33(4):562-5. doi: 10.1128/AAC.33.4.562.
8
Meropenem pharmacokinetics and penetration into an inflammatory exudate.
Antimicrob Agents Chemother. 1990 Aug;34(8):1515-7. doi: 10.1128/AAC.34.8.1515.
9
In vitro and in vivo activities of LJC10,627, a new carbapenem with stability to dehydropeptidase I.
Antimicrob Agents Chemother. 1991 Jan;35(1):203-7. doi: 10.1128/AAC.35.1.203.
10
Renal dehydropeptidase-I stability of LJC 10,627, a new carbapenem antibiotic.
Antimicrob Agents Chemother. 1992 Feb;36(2):481-3. doi: 10.1128/AAC.36.2.481.
本文引用的文献
1
PS-6 and PS-7, new beta-lactam antibiotics. Isolation, physicochemical properties and structures.
J Antibiot (Tokyo). 1980 Oct;33(10):1128-37. doi: 10.7164/antibiotics.33.1128.
2
Carpetimycins A and B, new beta-lactam antibiotics.
J Antibiot (Tokyo). 1980 Nov;33(11):1388-90. doi: 10.7164/antibiotics.33.1388.
3
Metabolism of thienamycin and related carbapenem antibiotics by the renal dipeptidase, dehydropeptidase.
Antimicrob Agents Chemother. 1982 Jul;22(1):62-70. doi: 10.1128/AAC.22.1.62.
4
PS-8, a minor carbapenem antibiotic.
J Antibiot (Tokyo). 1982 Jun;35(6):763-5. doi: 10.7164/antibiotics.35.763.
5
SQ 27,860, a simple carbapenem produced by species of Serratia and Erwinia.
J Antibiot (Tokyo). 1982 Jun;35(6):653-60. doi: 10.7164/antibiotics.35.653.
6
The structures of pluracidomycins, new carbapenem antibiotics.
J Antibiot (Tokyo). 1982 Apr;35(4):536-40. doi: 10.7164/antibiotics.35.536.
7
The carbapenem family.
J Antimicrob Chemother. 1982 Jul;10(1):4-7. doi: 10.1093/jac/10.1.4.
8
A novel beta-lactamase inhibitor, SF-2103 A produced by a Streptomyces.
J Antibiot (Tokyo). 1982 Apr;35(4):533-5. doi: 10.7164/antibiotics.35.533.
9
Asparenomycin A, a new carbapenem antibiotic.
J Antibiot (Tokyo). 1981 Jul;34(7):909-11. doi: 10.7164/antibiotics.34.909.
10
Comparative antibacterial properties in vitro of seven olivanic acid derivatives: MM 4550, MM 13902, MM 17880, MM 22380, MM 22381, MM 22382 and MM 22383.
J Antibiot (Tokyo). 1980 Aug;33(8):878-84. doi: 10.7164/antibiotics.33.878.
Zotero 插件